FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LIRAFUGRATINIB
异名/同义词2-PROPENAMIDE, N-(4-(4-AMINO-5-(3-FLUORO-4-((4-METHYL-2-PYRIMIDINYL)OXY)PHENYL)-7-METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-6-YL)PHENYL)-2-METHYL-
LIRAFUGRATINIB
LIRAFUGRATINIB [INN]
LIRAFUGRATINIB [USAN]
N-(4-(4-AMINO-5-(3-FLUORO-4-((4-METHYLPYRIMIDIN-2- YL)OXY)PHENYL)-7-METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-6- YL)PHENYL)-2-METHYLPROP-2-ENAMIDE
N-(4-(4-AMINO-5-(3-FLUORO-4-((4-METHYLPYRIMIDIN-2-YL)OXY)PHENYL)-7-METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-6-YL)PHENYL)METHACRYLAMIDE
RLY 4008 [WHO-DD]
RLY4008
RLY-4008
CAS登记号2549174-42-5
物质唯一标识(Unique Ingredient Identifier)7HY6IMH87S
分子式C28H24FN7O2
国际化合物标识(International Chemical Identifier,InChI)XOQVZSSDIQQUGO-UHFFFAOYSA-N
SMILESn1c(nc(cc1)C)Oc2c(F)cc(-c3c4c(ncnc4N)n(c3-c5ccc(NC(C(=C)C)=O)cc5)C)cc2
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System